Louisiana has picked its 'Netflix' hepatitis C partner: Gilead's new generics unit

Louisiana has picked its 'Netflix' hepatitis C partner: Gilead's new generics unit

Source: 
Fierce Pharma
snippet: 

Health and corrections officials in Louisiana are one step closer to treating thousands of hepatitis C patients who previously haven't had access to the latest drugs. The state chose Gilead Sciences’ new generics business, Asegua Therapeutics, to team up on its “Netflix” subscription model for unlimited access to an authorized Epclusa copycat.